|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|
| ASSETS | ||||
| Current assets: | ||||
| Cash and cash equivalents | ||||
| Accounts receivable, net | ||||
| Other receivables | ||||
| Related Party | ||||
| Nonrelated Party | ||||
| Inventories | ||||
| Prepaid expenses and other current assets | ||||
| Assets held for sale, current | ||||
| Total current assets | ||||
| Property, plant, and equipment, net | ||||
| Right-of-use assets | ||||
| Goodwill | ||||
| Intangible assets, net | ||||
| Other assets, noncurrent | ||||
| Assets held for sale, noncurrent | ||||
| Total assets | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
| Current liabilities: | ||||
| Lines of credit – working capital | ||||
| Lines of credit – wheat inventories | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Contract liabilities | ||||
| Current portion of long-term debt | ||||
| Contingent consideration liability | ||||
| Other liabilities, current | ||||
| Liabilities held-for-sale, current | ||||
| Total current liabilities | ||||
| Long-term debt | ||||
| Loan from related party | ||||
| Deferred tax liabilities, net | ||||
| Other liabilities, noncurrent | ||||
| Liabilities held for sale, noncurrent | ||||
| Total liabilities | ||||
| Ordinary shares, $0.001 par value; 100,000,000 authorized; 26,917,597 and 26,901,592 issued and outstanding, at December 31, 2025 and 2024, respectively | ||||
| Common Stock | ||||
| Total ordinary shares, $0.001 par value; 100,000,000 authorized; 26,917,597 and 26,901,592 issued and outstanding, at December 31, 2025 and 2024, respectively | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Accumulated other comprehensive loss | ||||
| Non-controlling interest | ||||
| Total Stockholders’ equity | ||||
| Total liabilities and Stockholders’ equity | ||||
Loading...
